华谊腾讯娱乐(00419.HK)续涨14% 料今年娱乐媒体业务分部收入大增
华谊腾讯娱乐(00419.HK)料今年娱乐及媒体业务分部收入大增,该股三连涨,承昨天重越10天及20天线势,今天升14%报0.58元,成交增至1.417亿股,涉资7,727万元。
华谊腾讯娱乐公布,随着电影《胜利号》和《迷途羔羊》上映,加上其他制作中项目如《Extinct》及《Moonfall(中文片名暂译为 》《月球陨落》)等陆续完成,集团预计今年度来自娱乐及媒体业务分部收入将按年大幅增加。另外,集团已签署投资意向书,有意投资一家发展中医药全产业链SaaS平台集团之少数股权,预计相关投资将於今年上半年完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.